{"id":"W1970048391","doi":"10.1586/14737140.3.4.435","title":"Second-line chemotherapy for non-small cell lung cancer","year":2003,"lang":"en","type":"review","venue":"Expert Review of Anticancer Therapy","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Docetaxel; Medicine; Vinorelbine; Pemetrexed; Oncology; Internal medicine; Gefitinib; Gemcitabine; Lung cancer; Erlotinib; Chemotherapy; Febrile neutropenia; Irinotecan; Taxane; Neutropenia; Pharmacology; Cancer; Epidermal growth factor receptor; Breast cancer; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002687414,0.0007833542,0.004103755,0.0001444568,0.00008430565,0.00001697022,0.0002812636,0.0002615646,0.003369862],"category_scores_gemma":[0.00001323338,0.0005168201,0.001674459,0.0004431501,0.00008837057,0.00005614724,0.00001540852,0.0002520511,0.00001002631],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003965548,"about_ca_system_score_gemma":0.002035213,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004317852,"about_ca_topic_score_gemma":0.000005857557,"domain_scores_codex":[0.9971834,0.00008483355,0.001229781,0.0007146992,0.0003091736,0.000478107],"domain_scores_gemma":[0.9975963,0.0001531006,0.0008400939,0.0008759323,0.000343793,0.0001907817],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003716135,0.0003361083,0.000006816461,0.1830026,0.001393322,0.000003706013,0.0001232898,3.602635e-8,0.00001717758,0.00002166921,0.03079705,0.784261],"study_design_scores_gemma":[0.00241838,0.0003448836,0.000001932154,0.1389039,0.001870307,0.00001411588,0.000006997995,0.000002862331,0.0002486209,0.000004264689,0.8557773,0.0004064828],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000003767697,0.9870608,0.0003576762,0.000533097,0.0007523861,0.008637145,0.0002801245,0.00003660927,0.002338336],"genre_scores_gemma":[7.425347e-7,0.9775298,0.003551387,0.008316216,0.0007562247,0.004631586,0.0003039394,0.00021593,0.004694233],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8249802,"threshold_uncertainty_score":0.9997283,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03951622257294597,"score_gpt":0.4335463687492299,"score_spread":0.3940301461762839,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}